FDA Inspection 973494 — QPharma AB

QPharma AB — FEI 3004620701

The FDA completed an inspection of QPharma AB on Jun 1, 2016 in Malmo. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jun 1, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Malmo (Sweden)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.